Long Term Outcome of Isolated First-Year C1q Positive Donor Specific Antibodies After Heart Transplantation

被引：0
|
作者：
Wakefield, Z. [1 ]
Bhatnagar, N. [1 ]
Kanungo, A. [1 ]
Hamilton, M. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Smidt Inst, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2024年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
180
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [31] C1Q STATUS AND TITER OF DE NOVO DONOR SPECIFIC ANTIBODIES ARE NOT PREDICTORS OF ALLOGRAFT SURVIVAL
    Wiebe, Chris
    Gareau, Alison
    Pochinco, Denise
    Gibson, Ian
    Ho, Julie
    Birk, Patricia
    Blydt-Hansen, Tom
    Karpinski, Martin
    Goldberg, Aviva
    Storsley, Leroy
    Rush, David
    Nickerson, Peter
    HUMAN IMMUNOLOGY, 2016, 77 : 72 - 72
  • [32] Correlation of C1q Binding in Patients with Donor Specific HLA Antibodies and Post Transplant Rejection
    Saltarrelli, J.
    Lappin, J.
    Katz, S.
    Varga, K.
    Van Buren, C.
    Bihari, L.
    Cook, D.
    Tyan, D.
    Kerman, R.
    Chen, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 290 - 290
  • [33] IDENTIFICATION AND CONSEQUENCES OF ANTIBODIES WHICH BOUND C1Q IN 118 KIDNEY TRANSPLANT RECIPIENTS WITH DONOR SPECIFIC ANTIBODIES
    Gautier, G.
    Caillard, S.
    Parissiadis, A.
    Olagne, J.
    Muller, C.
    Perrin, P.
    Braun, L.
    Heibel, F.
    Hanau, D.
    Moulin, B.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [34] DONOR SPECIFIC ANTIBODY AFTER HEART TRANSPLANT: IS C1Q ANTIBODY GENERATED FROM MEMORY B-CELLS?
    Helander, L.
    Roark, C. L.
    Freed, B. M.
    Everitt, M. D.
    HUMAN IMMUNOLOGY, 2021, 82 : 68 - 68
  • [35] The implication of genetic variation in the complement C3 allotypes on the first-year allograft outcome after live donor liver transplantation
    Awad, Samah Mohamed
    Taha, Mohammed
    Omar, Mahmoud
    Khalil, Ashraf
    TRANSPLANT IMMUNOLOGY, 2020, 60
  • [36] Average first-year brain natriuretic peptide predicts poor outcome after heart transplantation.
    Schaefer, BM
    Goldberg, SL
    O'Brien, KD
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S149 - S149
  • [37] The Impact of Complement-Binding Donor-Specific Antibodies on Adverse Events Long-Term after Heart Transplantation
    Kobashigawa, J. A.
    Kittleson, M.
    Chang, D. H.
    Kransdorf, E.
    Levine, R.
    Dimbil, S.
    Kawata, C.
    Olymbios, M.
    Velleca, A.
    Czer, L.
    Zhang, X.
    Chung, J.
    Patel, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S144 - S144
  • [38] LIMITED IMPACT OF PRE-EXISTING DONOR SPECIFIC HLA ANTIBODIES ON LONG TERM SURVIVAL AFTER FIRST LIVER TRANSPLANTATION
    Koch, M.
    Marget, M.
    Spetzler, V.
    Thude, H.
    Sterneck, M.
    Nashan, B.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 10 - 10
  • [39] C1Q BLOCKING EFFECTS OF NON-COMPLEMENT-BINDING DONOR SPECIFIC HLA-ANTIBODIES
    Honger, Gideon
    Amico, Patrizia
    Arnold, Marie-Luise
    Spriewald, Bernd M.
    Schaub, Stefan
    HLA, 2016, 87 (04) : 224 - 225
  • [40] Clinical Outcome of Patients With <i>De Novo</i> C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation
    Bamoulid, J.
    Roodenburg, A.
    Staeck, O.
    Schoenemann, C.
    Lachmann, N.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345